S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
pixel
pixel
Log in
AMEX:EHC

Encompass Health Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume620,391 shs
Average Volume618,344 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of November 16, 2020, Encompass Health Corporation operated 137 hospitals, 242 home health locations, and 83 hospice locations in 39 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Encompass Health logo

Industry, Sector and Symbol

Industry Medical Care Facilities
Sub-IndustryHealth Care Facilities
SectorMedical
CUSIP42192430
Phone+1-205-9677116
Employees43,000
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings Date4/27/2021 (Estimated)
OptionableOptionable

MarketRank

Overall MarketRank

1.62 out of 5 stars

Analyst Opinion: 3.5Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
30 days | 90 days | 365 days | Advanced Chart

Receive EHC News and Ratings via Email

Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Encompass Health (AMEX:EHC) Frequently Asked Questions

Is Encompass Health a buy right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last twelve months. There are currently 1 hold rating and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Encompass Health stock.
View analyst ratings for Encompass Health
or view top-rated stocks.

What stocks does MarketBeat like better than Encompass Health?

Wall Street analysts have given Encompass Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Encompass Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Encompass Health's next earnings date?

Encompass Health is scheduled to release its next quarterly earnings announcement on Tuesday, April 27th 2021.
View our earnings forecast for Encompass Health
.

How were Encompass Health's earnings last quarter?

Encompass Health Co. (AMEX:EHC) posted its quarterly earnings data on Monday, January, 25th. The company reported $0.93 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.86 by $0.07. The business earned $1.21 billion during the quarter, compared to the consensus estimate of $1.21 billion. Encompass Health's revenue was up 2.5% compared to the same quarter last year. During the same quarter last year, the business earned $0.85 EPS.
View Encompass Health's earnings history
.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Thursday, February 25th. Investors of record on Thursday, April 1st will be given a dividend of $0.28 per share on Thursday, April 15th. This represents a $1.12 dividend on an annualized basis and a dividend yield of ∞. The ex-dividend date is Wednesday, March 31st.
View Encompass Health's dividend history
.

Is Encompass Health a good dividend stock?

Encompass Health pays an annual dividend of $1.00 per share and currently has a dividend yield of 0.00%.
View Encompass Health's dividend history.

What guidance has Encompass Health issued on next quarter's earnings?

Encompass Health issued an update on its FY21 earnings guidance on Tuesday, January, 26th. The company provided EPS guidance of $3.31 to $3.53 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.83. The company issued revenue guidance of $5.000 billion to $5.170 billion, compared to the consensus revenue estimate of $5.06 billion.

What price target have analysts set for EHC?

11 equities research analysts have issued 12-month target prices for Encompass Health's stock. Their forecasts range from $83.00 to $106.00. On average, they expect Encompass Health's stock price to reach $92.18 in the next twelve months.
View analysts' price targets for Encompass Health
or view top-rated stocks among Wall Street analysts.

Who are Encompass Health's key executives?

Encompass Health's management team includes the following people:
  • Mr. Mark J. Tarr, CEO, Pres & Director (Age 59, Pay $2.77M)
  • Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 59, Pay $1.56M)
  • Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 56)
  • Ms. Barbara Ann Jacobsmeyer, Exec. VP & Pres of Inpatient Hospitals (Age 55)
  • Ms. April Kaye-Bullock Anthony, Chief Exec. Officer of Home Health & Hospice (Age 54, Pay $523.41k)
  • Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 54)
  • Mr. Rusty Yeager, Chief Information Officer & Sr. VP
  • Ms. Crissy Buchanan Carlisle, Chief Investor Relations Officer
  • Ms. Dawn Rock, Chief Compliance Officer
  • Mr. Anthony A. Hernandez, Chief HR Officer (Age 55)

Who are some of Encompass Health's key competitors?

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include NVIDIA (NVDA), Gilead Sciences (GILD), Pfizer (PFE), AT&T (T), Walmart (WMT), Netflix (NFLX), Verizon Communications (VZ), AbbVie (ABBV), Activision Blizzard (ATVI) and Chevron (CVX).

What is Encompass Health's stock symbol?

Encompass Health trades on the AMEX under the ticker symbol "EHC."

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does Encompass Health have?

Encompass Health employs 43,000 workers across the globe.

What is Encompass Health's official website?

The official website for Encompass Health is www.healthsouth.com.

Where are Encompass Health's headquarters?

Encompass Health is headquartered at 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States.

How can I contact Encompass Health?

Encompass Health's mailing address is 3660 Grandview Pkwy Ste 200, BIRMINGHAM, AL 35243-3332, United States. The company can be reached via phone at +1-205-9677116 or via email at [email protected]


This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.